ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 114 filers reported holding ALBIREO PHARMA INC in Q3 2020. The put-call ratio across all filers is 7.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,898,000 | +78.6% | 63,616 | +39.4% | 0.00% | 0.0% |
Q4 2021 | $1,063,000 | -49.1% | 45,647 | -31.8% | 0.00% | 0.0% |
Q3 2021 | $2,089,000 | -1.3% | 66,968 | +11.3% | 0.00% | 0.0% |
Q2 2021 | $2,116,000 | +19.4% | 60,156 | +19.6% | 0.00% | 0.0% |
Q1 2021 | $1,772,000 | +35.4% | 50,277 | +44.0% | 0.00% | 0.0% |
Q4 2020 | $1,309,000 | -11.5% | 34,909 | -21.2% | 0.00% | 0.0% |
Q3 2020 | $1,479,000 | +81.9% | 44,317 | +44.4% | 0.00% | 0.0% |
Q2 2020 | $813,000 | +80.7% | 30,691 | +11.6% | 0.00% | – |
Q1 2020 | $450,000 | -37.8% | 27,508 | -3.4% | 0.00% | -100.0% |
Q4 2019 | $724,000 | +83.8% | 28,464 | +44.5% | 0.00% | – |
Q3 2019 | $394,000 | -40.9% | 19,693 | -4.8% | 0.00% | -100.0% |
Q2 2019 | $667,000 | -10.7% | 20,688 | -10.8% | 0.00% | 0.0% |
Q1 2019 | $747,000 | +25.8% | 23,193 | -4.2% | 0.00% | 0.0% |
Q4 2018 | $594,000 | -40.8% | 24,216 | -20.4% | 0.00% | 0.0% |
Q3 2018 | $1,003,000 | +35.5% | 30,439 | +46.1% | 0.00% | 0.0% |
Q2 2018 | $740,000 | +38.8% | 20,840 | +27.4% | 0.00% | 0.0% |
Q1 2018 | $533,000 | – | 16,355 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |